Achillion to Present at 2012 Wells Fargo Securities Healthcare Conference

NEW HAVEN, Conn., June 14, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. ( ACHN ), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that Michael D. Kishbauch , President and Chief Executive Officer of Achillion , will present a corporate overview at the 2012 Wells Fargo Securities Healthcare Conference . The presentation will take place at the InterContinental Hotel in Boston, MA on Tuesday, June 19, 2012 at 11:15 a.m. EDT.

The live audio broadcasts and the subsequent archived webcasts of the Company's presentation will be available on the Company's website, http://www.achillion.com , under the "News Center" section. The audio recording will be archived for 30 days following the live presentation. Please connect to Achillion's website several minutes prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary.

About Achillion Pharmaceuticals

Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Achillion's proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease including HCV and resistant bacterial infections. For more information on Achillion Pharmaceuticals, please visit www.achillion.com or call 1-203-624-7000.

 Company Contact: 
 Glenn Schulman 
 Achillion Pharmaceuticals, Inc. 
 Tel. (203) 624-7000 
 gschulman@achillion.com 
 Investors: 
 Mary Kay Fenton 
 Achillion Pharmaceuticals, Inc. 
 Tel. (203) 624-7000 
 mfenton@achillion.com 
 Media: 
 Christin Culotta Miller 
 Ogilvy PR 
 Tel. (212) 880-5264 
 Christin.Miller@Ogilvy.com